3M partners for camera to make 3-D-printed dental products; Angel Medical raises $10M;

@FierceMedDev: #ICYMI: Epigenomics scores Chinese marketing approval for innovative colorectal cancer test. More | Follow @FierceMedDev

@EmilyWFierce: VertiFlex faces regulatory setback for spinal implant as #FDA delays panel meeting. Story | Follow @EmilyWFierce

> Angel Medical, developer of implantable ischemia monitoring devices, reported raising half of a planned $20.5 million debt offering. SEC Form

> 3M Health Care and Orange Business Services designed an intra-oral digital camera to securely provide digital scans to production centers where prosthetic and orthodontic works or moldings are produced via 3-D printers. Release

> Infraredx, a cardiovascular imaging company, released results from a study evaluating the ability of intravascular near-infrared spectroscopy (NIRS) to identify lipids as a means to predict the risk of future heart attacks. Release

> Aurora Spine Corporation, a spinal implant developer, received the Health Canada Medical Device License for its ZIP(TM) Interspinous Fusion System. Release

Biotech News

@FierceBiotech: Versant wraps up an over-stuffed $305M fund with eyes on Canada. Story | Follow @FierceBiotech

@DamianFierce: Fun thing about 2014's failed takeovers is drugmakers getting stuck with bluest-ever-sky sales projections. Story | Follow @DamianFierce

> R&D returns are getting better, but not by much and not for everyone, report says. Story

> Juno preps an IPO worth up to $191M amid CAR-T fever pitch. More

> Merck shows PD-1's promise in breast cancer with positive early results. Item

Pharma News

@FiercePharma: Goodbye Millennium brand, hello big commercial expansion for Takeda's cancer biz. More | Follow @FiercePharma

@CarlyHFierce: #ICYMI: Amgen hopes new data can give Kyprolis a jump on rival Pomalyst. Story | Follow @CarlyHFierce

> Kiss more pharma jobs goodbye: Pierre Fabre to cut 550 in sales, R&D. Story

> Mylan shells out $32.5M to execs to handle inversion-deal excise taxes. Article

> Mylan, Stada, Dr Reddy's drugs suspended after contractor's trial failures. News

Drug Delivery News

> Oramed raises funds for clinical development programs through stock sale. Story

> Unilife signs supply agreement for Depot-ject delivery system. More

> 3-D vaccine triggers immune response against cancer and infections. News

> Insys collects gastric cancer orphan designation for liposome-trapped paclitaxel. More

> NC State team creates 3-D printer for nanoparticles that offers low-cost production. Story

Diagnostics News

> British startup forges ahead with quick genome sequencing tech for rare childhood diseases. More

> Qiagen joins up with Altona to distribute Ebola diagnostic. News

> Epigenomics scores Chinese marketing approval for innovative colorectal cancer test. Report

> Eurofins Scientific gets in on specialized Dx with $140M Boston Heart purchase. Item

> Invitae scores CMS and Blue Shield of California coverage for genetic tests. Article

Pharma Marketing News

> Looking for a bright side to the Merck-Cubist merger? It's the power of the sales rep. Story

> Goodbye Millennium brand, hello big commercial expansion for Takeda's cancer biz. News

> Why spend money on awareness? A new study shows the campaigns actually work. More

> Amgen hopes new data can give Kyprolis a jump on rival Pomalyst. Story

> Novartis lays off 200 primary care reps as it preps for megablockbuster LCZ696 rollout. Article

Suggested Articles

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.